Pink Movement A Fight Against Cervical Cancer

The event was organized by Brainbox Inc, in cooperation with global pharmaceuticals company GlaxoSmithKline (GSK), Sorciage by Wacoal, Artistry by Amway, Healthway Medial, Magic 89.9 and Team Manila. The open-for-all-female dance marathon entitled “Pink Movement” was hosted by Iya Villania, JC Cuadrado and Dj Suzy of Magic 89.9. It also feature the popular hiphop dance group G Force’s head instructor and choreographer Georcelle Dapat-Sy. There were a lot of women (ages 15-35) from 21 schools and 16 studios from all over the metro that come together to fight the vicious cervical cancer.

It was a great and enriching event for it was a great way of reaching and informing young adults and women about cervical cancer – how to fight and prevent it.
Thanks to GMCI and Meei for inviting me! Let’s dance and live a healthy life now to prevent and fight this disease.
Fast Facts About Cervical Cancer:
Cervical cancer is the second most common cancer in women worldwide, with 500, 000 new cases and 250, 000 deaths reported each year. Over 80% of cases occur in developing countries including the Philippines, where it is ranked as the second most common cancer afflicting Filipino women. Yet few women realize that cervical cancer is actually treatable if diagnosed early.

Preventing Cervical Cancer through the Single Visit Approach (SVA), Cryotheraphy and Vaccination:
One of the primary goals of CECAP is to fund cervical cancer screenings throughout the Philippines by using the Single Visit Approach (SVA) and on-the spot treatment through cryotheraphy.
SVA: The SVA combines both screening and treatment in one session. It uses an affective, low-resource screening method called the Visual Inspection using Acetic Acid (VIA), a simple technique that uses vinegar to detect precancerous lesions on the cervix and requires much less equipment and time investment than PAP smear.

Cryotheraphy: a process where the areas with lesions are frozen using a common liquid coolant like carbon dioxide, effectively eliminating the abnormality and preventing possible progression to cancer.
Vaccination: GlaxoSmithKline’s cervical cancer vaccine provides significant protection for women against the two most common cancer-causing human papillomavirus (HPV) types (HPV types 16 and 18) for nearly six and a half years, the longest duration of protection reported to date. In fact, the GSK cervical cancer vaccine does not demonstrate, at the moment, the need for booster shot even after 6 years of vaccination. HPV types 16 and 18, together, are responsible for over 70 percent of cervical cancer cases in Asia Pacific. GSK’s cervical cancer vaccine has also shown efficacy against persistent infection caused by 12 other cancer-causing HPV types beyond HPV 16 and 18. Designed for both young and mature women, females from 10 years old onwards can be vaccinated using GSK’s cancer vaccine.
Photos from Pink Movement Event
Republiq, Resorts World
Newport City